Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
564,000
+12,000 (2.17%)
Feb 9, 2026, 3:19 PM KST

Hanmi Pharm. Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
6,999,4783,556,8004,473,4213,711,1673,373,8704,397,245
Market Cap Growth
103.69%-20.49%20.54%10.00%-23.27%25.97%
Enterprise Value
7,371,4824,027,0464,935,3544,226,7784,030,8795,216,052
Last Close Price
552000.00280500.00350901.20290409.65263266.61342142.63
PE Ratio
60.0929.3230.5944.8350.34367.69
Forward PE
38.0219.5430.5738.0144.6395.75
PS Ratio
4.772.383.002.792.804.09
PB Ratio
5.202.874.073.683.645.29
P/TBV Ratio
6.153.424.924.514.476.44
P/FCF Ratio
54.7323.0623.6528.1418.5440.08
P/OCF Ratio
40.3818.3820.6622.8716.7129.02
PEG Ratio
1.731.161.083.185.035.03
EV/Sales Ratio
5.032.693.313.173.354.85
EV/EBITDA Ratio
25.0913.0015.2616.8618.7947.28
EV/EBIT Ratio
37.6318.9521.9527.4732.14106.50
EV/FCF Ratio
57.6426.1126.0932.0522.1547.54
Debt / Equity Ratio
0.320.400.520.670.820.96
Debt / EBITDA Ratio
1.481.601.772.713.537.27
Debt / FCF Ratio
3.413.223.035.144.167.31
Asset Turnover
0.730.760.780.690.630.57
Inventory Turnover
2.152.302.382.372.041.56
Quick Ratio
0.820.630.610.620.670.56
Current Ratio
1.401.091.041.031.081.15
Return on Equity (ROE)
9.90%12.00%15.68%10.48%9.26%2.09%
Return on Assets (ROA)
6.10%6.78%7.35%4.98%4.11%1.61%
Return on Invested Capital (ROIC)
10.36%11.77%13.37%8.83%6.66%2.51%
Return on Capital Employed (ROCE)
13.50%15.90%18.80%12.30%9.70%3.60%
Earnings Yield
1.66%3.41%3.27%2.23%1.99%0.27%
FCF Yield
1.83%4.34%4.23%3.55%5.39%2.50%
Dividend Yield
0.23%0.45%----
Payout Ratio
26.49%10.35%12.31%7.24%8.77%68.07%
Buyback Yield / Dilution
0.03%0.08%0.09%0.12%0.11%0.09%
Total Shareholder Return
0.26%0.53%0.09%0.12%0.11%0.09%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.